FindTrial
Sign In

Paclitaxel (Taxol)

DRUG6 trials

Sponsors

M.D. Anderson Cancer Center, Hamamatsu University, SCRI Development Innovations, LLC, BioMimetix JV, LLC

Conditions

Breast CancerEndometrial Cancer, Endometrial NeoplasmEsophageal CancerGastric CancerNon-small Cell Lung CancerOvarian NeoplasmsPenile CancerProstate Cancer

Phase 1

Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma
CompletedNCT00038246
M.D. Anderson Cancer CenterProstate Cancer
Start: 2000-10-31End: 2004-12-31Updated: 2018-10-31
BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer
Not yet recruitingNCT06620029
BioMimetix JV, LLCEndometrial Cancer, Endometrial Neoplasm, Ovarian Neoplasms
Start: 2025-04-01End: 2027-07-31Target: 27Updated: 2024-10-01

Phase 2

Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer
CompletedNCT00006081
M.D. Anderson Cancer CenterEsophageal Cancer, Gastric Cancer
Start: 2000-06-30End: 2005-09-30Updated: 2012-07-30
Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis
CompletedNCT00512096
M.D. Anderson Cancer CenterPenile Cancer
Start: 1999-08-31End: 2010-08-31Updated: 2012-08-01
Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
CompletedNCT00752115
Hamamatsu UniversityNon-small Cell Lung Cancer
Start: 2007-02-28End: 2010-12-31Target: 120Updated: 2011-09-07

Phase 3

A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
CompletedNCT00789581
SCRI Development Innovations, LLCBreast Cancer
Start: 2008-12-31End: 2016-11-30Updated: 2017-07-02

Related Papers

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
2017-05-1520 citations
TITAN: Phase III study of doxorubicin/cyclophosphamide (AC) followed by ixabepilone (Ixa) or paclitaxel (Pac) in early-stage, triple-negative breast cancer (TNBC).
Journal of Clinical Oncology2015-05-205 citations